Expect Some Stent Patients to Be Switched to Clopidogrel

Questions are coming up about whether it's okay for patients to switch antiplatelet meds after a coronary stent.

Current guidelines prefer the combo of aspirin plus Brilinta (ticagrelor) or Effient (prasugrel) after an acute coronary syndrome...instead of aspirin plus clopidogrel.

Earlier studies suggest that Brilinta or Effient reduce CV risk more than clopidogrel...but they cause more bleeding and cost a lot more.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote